Are you Dr. Gajewski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 79 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2131 S 17th St
Wilmington, NC 28401Phone+1 910-667-3000Fax+1 910-667-6758- Is this information wrong?
Summary
- Dr. Walter Gajewski, MD is an obstetrician/gynecologist in Wilmington, North Carolina. He is currently licensed to practice medicine in North Carolina, Rhode Island, and Massachusetts. He is affiliated with Novant Health New Hanover Regional Medical Center and is an Obstetrician-gynecologist in Wilmington at North Carolina and is affiliated with New Hanover Regional Medical Center.
Education & Training
- Massachusetts General HospitalFellowship, Gynecologic Oncology, 1985 - 1987
- University of ConnecticutResidency, Obstetrics and Gynecology, 1982 - 1985
- Medical University of South CarolinaClass of 1982
Certifications & Licensure
- NC State Medical License 2004 - 2024
- RI State Medical License 1993 - 2006
- MA State Medical License 1986 - 2004
- CT State Medical License 1984 - 2004
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsCombining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer.Richard G. Moore, Douglas M. Hawkins, M. Craig Miller, Lisa M. Landrum, Walter H. Gajewski, John J. Ball, W. Jeffery Allard, Steven J. Skates> ;Gynecologic Oncology. 2014 Dec 1
- 77 citationsPhase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcin...Paul DiSilvestro, Shamshad Ali, Peter S. Craighead, Joseph A. Lucci, Yi-Chun Lee, David E. Cohn, Nicola M. Spirtos, Krishnasu S. Tewari, Carolyn Y. Muller, Walter H. G...> ;Journal of Clinical Oncology. 2014 Feb 10
- 183 citationsEvaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic MassRichard G. Moore, M. Craig Miller, Paul DiSilvestro, Lisa M. Landrum, Walter Gajewski, John J. Ball, Steven J. Skates> ;Obstetrics and Gynecology. 2011 Aug 1
- Join now to see all
Professional Memberships
- Fellow
- Member
Hospital Affiliations
- Novant Health New Hanover Regional Medical CenterWilmington, North Carolina